Incidence of Recurrent Pericarditis in Adults
The incidence of recurrent pericarditis after an initial episode of acute pericarditis ranges from 15-30%, and this risk increases to approximately 50% after a first recurrence in patients not treated with colchicine, particularly if corticosteroids were used. 1
Key Epidemiological Data
The recurrence rate is well-established across multiple guideline statements:
- After first episode: 15-30% of patients develop recurrent or incessant disease when not treated with colchicine 1
- After first recurrence: Risk escalates to approximately 50% in patients not receiving colchicine therapy 1
- With colchicine treatment: The recurrence rate can be reduced by approximately half 1
Temporal Pattern of Recurrences
Recent research reveals that recurrences are heavily front-loaded, with 86.8% occurring within the first 3 months after the index episode, and a median time to recurrence of just 35 days 2. This temporal clustering has important implications for monitoring intensity during the early post-acute phase.
Treatment-Related Risk Factors
The risk of recurrence is significantly influenced by initial management:
- Corticosteroid use is associated with higher recurrence rates and favors chronicity 1
- Inadequate treatment of the first episode (wrong drug choice, insufficient dose, inadequate duration, or improper tapering) is a common cause of recurrence 1
- Colchicine omission approximately doubles the recurrence risk 1
Clinical Context
In developed countries, most cases are idiopathic or presumed viral/immune-mediated in immunocompetent patients 1. When virological studies are performed on pericardial fluid and tissue, a viral etiology is detected in up to 20% of recurrent cases 1.
Important Caveats
- These incidence figures apply primarily to idiopathic/viral pericarditis; specific etiologies (bacterial, tuberculous, autoimmune, neoplastic) have different recurrence patterns
- The 15-30% baseline rate reflects patients not optimally treated with colchicine, which was not standard practice in earlier cohorts
- Contemporary studies with routine colchicine use show lower recurrence rates, closer to 9% in some series of uncomplicated cases 3
- Approximately 30% of patients experience recurrence within 18 months after a first episode 1
The substantial variation in reported rates (9-30%) reflects differences in patient populations, treatment protocols (particularly colchicine use), follow-up duration, and whether studies included only uncomplicated cases versus all-comers.